Microdissection-Based p53 Genotyping: Concepts for Molecular Testing.

作者: S FINKELSTEIN , R PRZYGODZKI , P SWALSKY

DOI: 10.1016/S1084-8592(98)80037-4

关键词:

摘要: p53 is the most commonly altered tumor-suppressor gene in humans, involved development and progression of many diverse forms human cancer. Although much remains to be learned about biology this important growth regulatory gene, sufficient experience has been accumulated with respect occurrence pattern mutational change justify molecular diagnostic testing for specific objectives. The authors outline concepts particular emphasis solid tumor diagnostics. This article focuses on microdissection-based fixed tissue analysis, introducing new considerations related quality control appropriate type methodology. Given rapidly evolving nature genetics, suggestions provided here should viewed as flexible. Nevertheless, are intended serve a model other oncogene/tumor suppressor-gene assays developed overall purpose establishing informative integrated histopathologic/genetic complement standard microscopic analysis.

参考文章(39)
Fishback N, Przygodzki Rm, Guinee Dg, Bakker A, Finkelstein Sd, Koss M, Travis Wd, Swalsky Pa, Langer Jc, Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. American Journal of Pathology. ,vol. 148, pp. 1531- 1541 ,(1996)
Gollin Sm, Pollack If, Hamilton Rl, Campbell Jw, Finkelstein Sd, Sherwin Rn, Bozik Me, Martinez Aj, The Relationship between TP53 Mutations and Overexpression of p53 and Prognosis in Malignant Gliomas of Childhood Cancer Research. ,vol. 57, pp. 304- 309 ,(1997)
Phouthone Keohavong, Joel Weissfeld, Dan Zhu, Anke Bakker, Theresa L. Whiteside, Sydney D. Finkelstein, Patricia Swalsky, Sudhir Srivastava, K-ras Gene Mutations in Normal Colorectal Tissues from K-ras Mutation-positive Colorectal Cancer Patients Cancer Research. ,vol. 57, pp. 2485- 2492 ,(1997)
A G Knudson, Antioncogenes and human cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 10914- 10921 ,(1993) , 10.1073/PNAS.90.23.10914
Michael Weller, Predicting response to cancer chemotherapy: the role of p53 Cell and Tissue Research. ,vol. 292, pp. 435- 445 ,(1998) , 10.1007/S004410051072
AMAL Kanbour-Shakir, SOPHIA Kounelis, HELEN Papadaki, S Raptis, RP Edwards, JL Kelley III, FV Price, A Bakker, PA Swalsky, RM Przygodzki, SD Finkelstein, Relationship of p53 Genotype to Second-look Recurrence and Survival in Ovarian Epithelial Malignancy. Molecular Diagnosis. ,vol. 1, pp. 121- 129 ,(1996) , 10.1016/S1084-8592(96)70027-9
T. Ito, T. Seyama, T. Hayashi, T. Mizuno, K.S. Iwamoto, N. Tsuyama, K. Dohi, N. Nakamura, M. Akiyama, HaeIII polymorphism in intron 1 of the human p53 gene. Human Genetics. ,vol. 93, pp. 222- 222 ,(1994) , 10.1007/BF00210619
Svetlana Rechitsky, Michael Freidine, Yury Verlinsky, Charles M. Strom, Allele dropout in sequential PCR and FISH analysis of single cells (cell recycling) Journal of Assisted Reproduction and Genetics. ,vol. 13, pp. 115- 124 ,(1996) , 10.1007/BF02072532
M Fresno, R Molina, M.J.Pérez del Río, S Alvarez, J.M Díaz-Iglesias, I García, A Herrero, p53 expression is of independent predictive value in lymph node-negative breast carcinoma European Journal of Cancer. ,vol. 33, pp. 1268- 1274 ,(1997) , 10.1016/S0959-8049(97)00096-8